Novel methods and technologies for 21st-century clinical trials: a review

JAMA Neurology
E Ray DorseyKarl Kieburtz

Abstract

New technologies are rapidly reshaping health care. However, their effect on drug development to date generally has been limited. To evaluate disease modeling and simulation, alternative study design, novel objective measures, virtual research visits, and enhanced participant engagement and to examine their potential effects as methods and tools on clinical trials. We conducted a systematic search of relevant terms on PubMed (disease modeling and clinical trials; adaptive design, clinical trials, and neurology; Internet, clinical trials, and neurology; and telemedicine, clinical trials, and neurology), references of previous publications, and our files. The search encompassed articles published from January 1, 2000, through November 30, 2014, and produced 7976 articles, of which 22 were determined to be relevant and are included in this review. Few of these new methods and technologies have been applied to neurology clinical trials. Clinical outcomes, including cognitive and stroke outcomes, increasingly are captured remotely. Other therapeutic areas have successfully implemented many of these tools and technologies, including web-enabled clinical trials. Increased use of new tools and approaches in future clinical trials can e...Continue Reading

Citations

Jun 25, 2016·Journal of Huntington's Disease·Kelly L AndrzejewskiE Ray Dorsey
Mar 2, 2017·The New England Journal of Medicine·Christine GradyGagandeep Kang
Apr 18, 2017·Clinical Therapeutics·Irl B HirschSpyros Papapetropoulos
Jul 19, 2017·Expert Review of Clinical Pharmacology·Edoardo FerlazzoUmberto Aguglia
Apr 7, 2018·Nature Reviews. Neurology·E Ray DorseyLee H Schwamm
Dec 9, 2017·BMC Medical Research Methodology·Belinda von NiederhäusernChristiane Pauli-Magnus
Sep 22, 2018·Nature Reviews. Drug Discovery·Nicholas S CaronMichael R Hayden
Jul 7, 2017·Stroke; a Journal of Cerebral Circulation·Bruce H Dobkin, Andrew K Dorsch
Jan 5, 2019·Therapeutic Innovation & Regulatory Science·Stella StergiopoulosKenneth A Getz
Feb 16, 2016·Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring·Adriana SeelyeJeffrey A Kaye
Dec 24, 2019·Journal of Huntington's Disease·Karthik DineshJamie L Adams
Jun 30, 2018·Alzheimer's & Dementia : Translational Research & Clinical Interventions·Michael GoldSara J Czaja
Jul 13, 2016·Journal of Clinical Psychopharmacology·Margaret C GrabbJames T McCracken
Apr 28, 2016·Academic Medicine : Journal of the Association of American Medical Colleges·E Ray DorseyStephen H Friend
Aug 27, 2015·Movement Disorders : Official Journal of the Movement Disorder Society·Karl Kieburtz, C Warren Olanow
May 24, 2017·Current Hematologic Malignancy Reports·Catherine J Lee, Lori S Muffly
Jan 16, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·Jane S PaulsenYing Zhang
Jan 25, 2018·NPJ Digital Medicine·P Murali DoraiswamyHusseini K Manji
Sep 8, 2020·Journal of Parkinson's Disease·Christopher G TarolliTanya Simuni
May 27, 2016·Movement Disorders : Official Journal of the Movement Disorder Society·Charles S VenutoKarl Kieburtz
Oct 8, 2018·Current Neurology and Neuroscience Reports·Bruce H Dobkin, Clarisa Martinez
May 15, 2020·Journal of Neurology, Neurosurgery, and Psychiatry·Aleksandar VidenovicUNKNOWN Treatment and Trials Working Group of the International RBD Study Group
Dec 5, 2019·The Journal of the Acoustical Society of America·Rick P C Cousins
Jun 23, 2020·Journal of Parkinson's Disease·Ruth B SchneiderE Ray Dorsey
Nov 2, 2019·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Adam L BoxerNadine Tatton
Jun 21, 2018·Journal of Medical Internet Research·Susie DonnellyBrian Caulfield
Dec 23, 2020·Annals of Clinical and Translational Neurology·Ruth B SchneiderUNKNOWN Parkinson Study Group AT-HOME PD Investigators
Jan 23, 2021·Patient Education and Counseling·Ellie CourtneyMarkus Reuber
Sep 17, 2020·Parkinsonism & Related Disorders·Roongroj Bhidayasiri, Zoltan Mari
Apr 6, 2021·Journal of Huntington's Disease·Emma M WaddellJamie L Adams
Mar 12, 2020·Thérapie·Patrice NonyUNKNOWN CRESim, Epi-CRESim research groups
Mar 20, 2020·Neurology. Clinical Practice·Christopher G TarolliJamie L Adams

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Annals of African Medicine
Isyaku Mohammed
JPMA. the Journal of the Pakistan Medical Association
Quratulain Shaikh, Ayeesha Kamran Kamal
Current Medical Research and Opinion
David A Provenzano, Eugene R Viscusi
Revista médica de Chile
Ariel CastroGraciela Rojas
© 2022 Meta ULC. All rights reserved